Content
05/30/2024
Somerville, MA USA
Circe Bioscience
completed $8 million Series A Round funding. Investors include
Undeterred Capital, ReGen Ventures, Ponderosa Ventures, Elementum Ventures, Bee Partners.
About
Circe, a startup developed at the Wyss Institute and spun out of Harvard, has signed a worldwide, exclusive licensing agreement coordinated by Harvard's Office of Technology Development (OTD) to commercialize a novel bioproduction technology that could significantly reduce the carbon emissions of industries from food to aviation fuel.
Startup
Sector:
Biotech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
